San Francisco, CA, United States of America

Alexis Howerton

This inventor holds 10 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignee: Spruce Biosciences, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexis Howerton. Retrieved from https://idiyas.com/inventor/alexis-howerton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 11)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 69(Granted Patents)

Location History:

San Francisco, CA (US) (2020 - 2022)
South San Francisco, CA (US) (2024)

Company Filing History:

10 out of 13

Spruce Biosciences, Inc.

patents

Years Active: 2020-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576084 - Methods for treating testicular and ovarian adrenal rest tumors (2026-03-17),

2. 12569491 - Methods for treating testicular and ovarian adrenal rest tumors (2026-03-10),

3. 12569490 - Methods for treating testicular and ovarian adrenal rest tumors (2026-03-10),

4. 12115166 - Corticotropin releasing factor receptor antagonists (2024-10-15),

5. 11351177 - Corticotropin releasing factor receptor antagonists (2022-06-07),

6. 11344557 - Corticotropin releasing factor receptor antagonists (2022-05-31),

7. 11311549 - Corticotropin releasing factor receptor antagonists (2022-04-26),

8. 11304950 - Methods for treating testicular and ovarian adrenal rest tumors (2022-04-19),

9. 11007201 - Corticotropin releasing factor receptor antagonists (2021-05-18),

10. 10849908 - Corticotropin releasing factor receptor antagonists (2020-12-01),

Title: The Innovative Contributions of Alexis Howerton

Introduction

Alexis Howerton is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for congenital adrenal hyperplasia (CAH). With a total of 10 patents to her name, Howerton's work is paving the way for advancements in medical therapies.

Latest Patents

Among her latest patents, Howerton has developed novel pharmaceutical compositions that include -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine. These compositions are designed for the treatment of congenital adrenal hyperplasia (CAH), showcasing her commitment to addressing critical health issues.

Career Highlights

Howerton is currently associated with Spruce Biosciences, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her expertise and dedication have positioned her as a key player in her field.

Collaborations

Throughout her career, Howerton has collaborated with notable professionals, including Hal Gerber and Michael Guanran Huang. These partnerships have further enhanced her research and development efforts.

Conclusion

Alexis Howerton's innovative work and dedication to improving medical treatments exemplify the impact of inventors in the pharmaceutical industry. Her contributions are vital for advancing healthcare solutions.

Profile summary based on public USPTO records.